AusBiotech is calling for member contributions for the September 2023 edition of the Australasian Biotechnology journal.
AusBiotech is welcoming abstracts from valued members on advancing Australian capabilities with themes including medicines and manufacturing, and taking Australian Inc global, with articles sought on new approaches, contributions or analyses to include in the September 2023 edition of the Australasian Biotechnology Journal.
The journal will also feature a sneak peek into the October’s premier annual conferences, AusBiotech 2023 and AusBioInvest 2023, where local and global thought leaders discuss the latest research, technologies, challenges and market access strategies, and what Australia is bringing to the life sciences world-stage.
Australasian Biotechnology is AusBiotech’s official biannual journal, and published in September and April. Its contributions are written by the sector, for the sector. Contributions can range on topics including innovative medicine development, mass manufacturing, Australian strengths and successes on the world stage, and approaches to strengthening Australia’s end-to-end life sciences value chain.
With its informed and authoritative editorials, Australasian Biotechnology is a highly-effective communications vehicle for those wanting to reach stakeholders in the life sciences sector. The journal is mailed on a name-and-title basis to more than 3,000 AusBiotech members and investors, as well as published digitally. Readership includes companies, government and university departments, research institutes, biotechnology and professional services providers nationally, and in key overseas markets.
